Valiant Laboratories Ltd
NSE: VALIANTLAB | BSE: 543998
₹79.11
₹-0.83
(-1.04%)
As on 08-May-2026IST
Market cap
₹441 Cr
Revenue (TTM)
₹203 Cr
P/E Ratio
--
P/B Ratio
1.4
Div. Yield
0 %
Quality Score
1/10
Growth Score
2/10
Valuation Score
3/10
Momentum Score
5/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-4 Cr
-
ROE
-0.9 %
-
ROCE
-0.4 %
-
Industry P/E
35.63
-
EV/EBITDA
90.5
-
Debt to Equity
0.5
-
Book Value
₹57.1
-
EPS
₹-0.7
-
Face value
10
-
Shares outstanding
54,312,500
Years Aggregate
CFO
₹--
EBITDA
₹--
Net Profit
₹--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Valiant Lab
| 13.0 | 33.7 | 34.4 | -13.7 | -- | -- | -- |
|
BSE Healthcare
| 7.1 | 11.7 | 10.9 | 10.9 | 26.2 | 14.1 | 11.7 |
|
Company
|
2025
|
2024
|
|---|---|---|
|
Valiant Lab
| -32.4 | -36.6 |
|
BSE Small Cap
| -6.6 | 29.0 |
|
BSE Healthcare
| -3.3 | 43.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Valiant Lab
|
79.1 | 441.3 | 203.3 | -4.3 | 0.9 | -1.6 | -- | 1.4 |
| 1,121.3 | 13,757.5 | 2,512.3 | 543.7 | 28.3 | 19.3 | 25.3 | 4.3 | |
| 490.5 | 8,518.0 | 1,053.1 | 293.6 | 32.3 | 24.6 | 29 | 6.6 | |
| 1,173.9 | 12,294.0 | 1,158.7 | 309.6 | 31.9 | 17.3 | 39.3 | 6.5 | |
| 1,643.0 | 31,123.0 | 9,203.5 | 941.3 | 15.4 | 19.6 | 33.7 | 6.3 | |
| 398.5 | 4,341.7 | 159.3 | 47.8 | 39.0 | 18.6 | 90.9 | 15.7 | |
| 17,666.0 | 22,700.8 | 1,575.1 | 179.1 | 14.9 | 11.4 | 126.7 | 13.7 | |
| 965.6 | 4,451.3 | 588.5 | 102.9 | 22.1 | 12.7 | 43.8 | 5.3 | |
| 658.0 | 7,454.0 | 502.0 | 138.7 | -- | 32.8 | 53.7 | 8.6 | |
| 223.0 | 5,911.3 | 7.1 | -274.7 | -4,008.3 | -140.4 | -- | 8.9 |
Shareholding Pattern
View DetailsNews & Analysis
All News
4 min read•By Satyajit Sen
About Valiant Lab
Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States... pharmacopoeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also offers specialty chemicals. The company was formerly known as Bharat Chemicals and changed its name to Valiant Laboratories Limited in August 2021. The company was founded in 1980 and is based in Mumbai, India. Valiant Laboratories Limited is a subsidiary of Dhanvallabh Ventures LLP. Read more
-
Incorporated
2021
-
Chairman
--
-
Managing Director
Santosh S Vora
-
Headquarters
Mumbai, Maharashtra
-
Website
Looking for more details about Valiant Laboratories Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Valiant Lab
What is the current share price of Valiant Laboratories Ltd Today?
The share price of Valiant Laboratories Ltd is ₹79.11 (NSE) and ₹81.25 (BSE) as of 08-May-2026 IST. Valiant Laboratories Ltd has given a return of -13.73% in the last 1 years.
What is the current PB & PE ratio of Valiant Laboratories Ltd?
Since, TTM earnings of Valiant Laboratories Ltd is negative, P/E ratio is not available.
The P/B ratio of Valiant Laboratories Ltd is 1.42 times as on 08-May-2026, a 42 discount to its peers’ median range of 2.44 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
1.42
|
|
2024
|
1,837.23
|
2.67
|
|
2023
|
0.00
|
0.00
|
|
2025
|
0.00
|
1.42
|
|
2024
|
1,837.23
|
2.67
|
What is the 52 Week High and Low of Valiant Laboratories Ltd?
The 52-week high and low of Valiant Laboratories Ltd are Rs 115.54 and Rs 49.51 as of 08-May-2026.
What is the market cap of Valiant Laboratories Ltd?
Valiant Laboratories Ltd has a market capitalisation of ₹ 441 Cr as on 08-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Valiant Laboratories Ltd?
Before investing in Valiant Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.